Sentence examples for prior suppression from inspiring English sources

Virologic failure (defined as a plasma HIV RNA greater than 50 copies/ml) was associated with low recent CD4+ T cell count, low past adherence, shorter duration of prior suppression, and intravenous drug use.

The results of the present study demonstrate that prior suppression of lipolysis effectively normalizes glucose infusion rate during hyperinsulinaemia in Type 2 diabetes, but has no effect upon the rate of muscle glycogen synthesis.

Virological failure was defined if a confirmed HIV RNA level > 400 copies/mL after 24 weeks of antiretroviral treatment, or > 50 copies/mL after 48 weeks, or repeated detectable HIV RNA level after prior suppression of viremia.

Halorhodopsin has been previously well characterized (e.g. Zhang et al., Nature, 2007; Gradinaru et al., Brain Cell Bio, 2008), the virus has been used in several prior suppression experiments (e.g. Land et al., Nat. Neuro. 2014; Delevich et al., J. Neurosci. 2015; McCutcheon et al., Front. Neur. Circ. 2014) and we verified successful infection in TRN (the new Figure 4 figure supplement 2).

Prior suppression of plasma NEFAs by acipimox brought about a 23% increase in the glucose disposal rate in the Type 2 diabetic group (6.2±0.8 compared with 4.8±0.6 mg·kgffm−1·min−1, acipimox compared with placebo respectively, P=0.005; Figure 2A), so that it approached that of the control group (6.6±0.5 mg·kgffm−1·min−1; P=0.72).

These effects were estimated within subpopulations defined by duration of prior viral suppression.

Prior to suppression assays, the IL-10-producing fraction of Tr1-polarized cells was enriched with the IL-10-producing-cell isolation kit (Miltenyi Biotec), following the manufacturer's instructions.

The majority of applied GKT procedures use low probability probes, so although our first experiment was theoretically important for prior memory suppression work, the second experiment with low probability probes was most relevant to practical applications.

Figure 3 shows the mortality for IRs vs. INRs stratified by time from first CD4 measurement ≤ 200 cells/μL to start of of the virologically suppressed period and from this analysis it is seen, that the main excess mortality was observed in the INRs with more than one year of immunological suppression prior to the virologically suppressed period.

When excluding these patients from the analysis the unadjusted MRR was reduced to 3.1 (95%CI; 0.6 - 17.7) and after adjustment for age and gender it was 1.8 (95%CI; 0.3 - 10.2). 90 (70.3%) of the 128 patients who had more than one year of immunological suppression prior to the virologically suppressed period were diagnosed before 1995.

For eluent suppression prior to conductivity detection, a Dionex AERS 500 was used at a current setting of 22 mA.